Caveolin-1 in sarcomas: friend or foe?
Miguel Sáinz-Jaspeado1, Juan Martin-Liberal, Laura Lagares-Tena
1Sarcoma Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain.
Oncotarget
|April 8, 2011
Summary
Caveolin-1, a protein involved in cancer processes, has dual roles in sarcoma progression. Its function as a tumor suppressor early on shifts to promoting growth in advanced, metastatic, and drug-resistant sarcomas.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sarcomas are complex tumors with poorly understood pathogenesis and limited treatment options.
- Caveolin-1 is a scaffolding protein regulating key cancer processes like growth, metastasis, and drug resistance.
- Caveolin-1's role in cancer, particularly sarcomas, is context-dependent and not fully elucidated.
Purpose of the Study:
- To review the multifaceted role of caveolin-1 in soft tissue and bone sarcomas.
- To explore caveolin-1's potential as a diagnostic and prognostic biomarker in sarcomas.
- To discuss caveolin-1 as a possible therapeutic target for sarcoma treatment.
Main Methods:
- Literature review focusing on caveolin-1's function in sarcoma.
- Analysis of studies investigating caveolin-1 expression in various sarcoma types.
- Synthesis of evidence regarding caveolin-1's dual role in early-stage versus advanced sarcoma.
Main Results:
- Caveolin-1 acts as a tumor suppressor in early cancer development.
- Caveolin-1 is frequently upregulated in multidrug-resistant and metastatic sarcomas.
- Evidence suggests context-dependent functions of caveolin-1 in sarcoma signaling pathways.
Conclusions:
- Caveolin-1 exhibits a dichotomous role in sarcoma progression, acting as a suppressor initially and promoter later.
- Caveolin-1 warrants further investigation as a potential biomarker for sarcoma diagnosis and prognosis.
- Targeting caveolin-1 may offer a novel therapeutic strategy for advanced sarcomas.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...